Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David Christopher Christiani, M.D.

Co-Author

This page shows the publications co-authored by David Christiani and Norman Nishioka.
Connection Strength

0.502
  1. Interactions among genetic variants in apoptosis pathway genes, reflux symptoms, body mass index, and smoking indicate two distinct etiologic patterns of esophageal adenocarcinoma. J Clin Oncol. 2010 May 10; 28(14):2445-51.
    View in: PubMed
    Score: 0.113
  2. Genetic polymorphisms of VEGF, interactions with cigarette smoking exposure and esophageal adenocarcinoma risk. Carcinogenesis. 2008 Dec; 29(12):2330-4.
    View in: PubMed
    Score: 0.101
  3. A functional epidermal growth factor (EGF) polymorphism, EGF serum levels, and esophageal adenocarcinoma risk and outcome. Clin Cancer Res. 2008 May 15; 14(10):3216-22.
    View in: PubMed
    Score: 0.099
  4. XRCC1 and XPD polymorphisms and esophageal adenocarcinoma risk. Carcinogenesis. 2007 Jun; 28(6):1254-8.
    View in: PubMed
    Score: 0.090
  5. Polymorphisms of DNA repair and glutathione s-transferase genes and progression-free survival (PFS) in treated advanced esophageal cancer (EC) patients. J Clin Oncol. 2004 Jul 15; 22(14_suppl):9564.
    View in: PubMed
    Score: 0.076
  6. Polymorphisms of inflammatory and metalloproteinase genes, Helicobacter pylori infection and the risk of oesophageal adenocarcinoma. Br J Cancer. 2008 Feb 26; 98(4):689-92.
    View in: PubMed
    Score: 0.024
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.